Comm min withdraws rule for track, trace system for export of drug formulations
DGFT has decided to streamline export regulations by aligning with the evolving regulatory framework of the Ministry of Health & Family Welfare. Accordingly, the provisions related to the track and trace system for pharmaceutical exports under the Foreign Trade Policy are being withdrawn
image for illustrative purpose
New Delhi: The Commerce Ministry on Friday said it has withdrawn the provisions related to the track and trace system for pharmaceutical exports under the foreign trade policy. The implementation of the authentication system for drug formulations being exported will be undertaken by the Ministry of Health and Family Welfare in line with the provisions under Drug Rules 1945, according to a public notice of the Directorate General of Foreign Trade (DGFT).
The ministry said: "The DGFT has decided to streamline export regulations by aligning with the evolving regulatory framework of the Ministry of Health & Family Welfare. Accordingly, the provisions related to the track and trace system for pharmaceutical exports under the Foreign Trade Policy are being withdrawn."
The system, introduced on January 10, 2011, mandated barcoding at various packaging levels. While tertiary and secondary packaging requirements were successfully implemented in 2011 and 2013, primary-level barcoding and parent-child data uploading faced operational challenges and were repeatedly deferred, with the last extension valid until February 1, 2025. It added that the health ministry has already implemented barcode/QR code requirements for 300 drug brands under the Drugs Rules, 1945, from August 1, 2023, with plans for further expansion.
The move also assumes significance as most export destinations have their own serialization requirements, ensuring product traceability without additional domestic regulations. "With this step, DGFT is enhancing ease of doing business for pharmaceutical exporters while ensuring regulatory coherence," it added.
